BACKGROUND: Diabetes mellitus is associated with an increased risk for cognitive impairment and vascular factors seem to play a role in this relationship. In a sample involving elderly African Americans, we tested the hypothesis that diabetes accelerates cognitive decline and explored possible mediating mechanisms within a follow-up period of 15 years. METHODS: A total of 1,702 subjects, of whom 441 had diabetes, were given the community screening interview for dementia to measure cognitive functioning at six different time points spread over a 15-year follow-up period. Mixed effects models with repeated measures were used to examine the association of diabetes and vascular risk factors with cognitive scores over time. RESULTS: African American subjects with diabetes reported having a significant accelerated cognitive decline as compared with those without diabetes (P = .046), when controlling for basic demographics and baseline comorbid conditions (heart disease, hypertension, stroke, and depression). Adjusting for incident heart disease, and especially stroke, weakened this association (P = .098), thereby indicating a mediating effect of stroke on the association between diabetes and cognitive decline. However, when incident stroke was incorporated into the model, the effect for participants with diabetes increased greatly (P = .007). CONCLUSIONS: Diabetes, mediated by cerebrovascular pathology, accelerates cognitive decline within a follow-up period of 15 years in a sample comprising African Americans.
BACKGROUND:Diabetes mellitus is associated with an increased risk for cognitive impairment and vascular factors seem to play a role in this relationship. In a sample involving elderly African Americans, we tested the hypothesis that diabetes accelerates cognitive decline and explored possible mediating mechanisms within a follow-up period of 15 years. METHODS: A total of 1,702 subjects, of whom 441 had diabetes, were given the community screening interview for dementia to measure cognitive functioning at six different time points spread over a 15-year follow-up period. Mixed effects models with repeated measures were used to examine the association of diabetes and vascular risk factors with cognitive scores over time. RESULTS: African American subjects with diabetes reported having a significant accelerated cognitive decline as compared with those without diabetes (P = .046), when controlling for basic demographics and baseline comorbid conditions (heart disease, hypertension, stroke, and depression). Adjusting for incident heart disease, and especially stroke, weakened this association (P = .098), thereby indicating a mediating effect of stroke on the association between diabetes and cognitive decline. However, when incident stroke was incorporated into the model, the effect for participants with diabetes increased greatly (P = .007). CONCLUSIONS:Diabetes, mediated by cerebrovascular pathology, accelerates cognitive decline within a follow-up period of 15 years in a sample comprising African Americans.
Authors: Michael D Murray; Kathleen A Lane; Sujuan Gao; Rebecca M Evans; Frederick W Unverzagt; Kathleen S Hall; Hugh Hendrie Journal: Arch Intern Med Date: 2002-10-14
Authors: H C Hendrie; A Ogunniyi; K S Hall; O Baiyewu; F W Unverzagt; O Gureje; S Gao; R M Evans; A O Ogunseyinde; A O Adeyinka; B Musick; S L Hui Journal: JAMA Date: 2001-02-14 Impact factor: 56.272
Authors: Olivia I Okereke; Jae H Kang; Nancy R Cook; J Michael Gaziano; JoAnn E Manson; Julie E Buring; Francine Grodstein Journal: J Am Geriatr Soc Date: 2008-04-01 Impact factor: 5.562
Authors: Lawrence S Honig; Ming-Xin Tang; Steven Albert; Rosanne Costa; Jose Luchsinger; Jennifer Manly; Yaakov Stern; Richard Mayeux Journal: Arch Neurol Date: 2003-12
Authors: Jesse Mez; Jaeyoon Chung; Gyungah Jun; Joshua Kriegel; Alexandra P Bourlas; Richard Sherva; Mark W Logue; Lisa L Barnes; David A Bennett; Joseph D Buxbaum; Goldie S Byrd; Paul K Crane; Nilüfer Ertekin-Taner; Denis Evans; M Daniele Fallin; Tatiana Foroud; Alison Goate; Neill R Graff-Radford; Kathleen S Hall; M Ilyas Kamboh; Walter A Kukull; Eric B Larson; Jennifer J Manly; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Gerard D Schellenberg; Kathryn L Lunetta; Lindsay A Farrer Journal: Alzheimers Dement Date: 2016-10-20 Impact factor: 21.566
Authors: Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman Journal: Clin Neuropsychol Date: 2015-05-15 Impact factor: 3.535
Authors: Jamie L Hamilton; Adam M Brickman; Rosalyn Lang; Goldie S Byrd; Jonathan L Haines; Margaret A Pericak-Vance; Jennifer J Manly Journal: J Int Neuropsychol Soc Date: 2014-05-19 Impact factor: 2.892
Authors: Hugh C Hendrie; Mengjie Zheng; Kathleen A Lane; Roberta Ambuehl; Christianna Purnell; Shanshan Li; Frederick W Unverzagt; Michael D Murray; Ashok Balasubramanyam; Chris M Callahan; Sujuan Gao Journal: Alzheimers Dement Date: 2018-04-18 Impact factor: 21.566